Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6202955 | 7010182 | I | 6202955-1 | 20090314 | 20090508 | 20090519 | EXP | 2009AP001882 | APOTEX INC. | 75 | YR | N | 20090518 | UNITED KINGDOM |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6202955 | 1011628960 | PS | ALENDRONATE SODIUM | 1 | ORAL | 70 MG;QW PO | D | D | 77982 | ||
| 6202955 | 1011660309 | C | ASPIRIN | 1 | |||||||
| 6202955 | 1011660310 | C | BUMETANIDE | 1 | |||||||
| 6202955 | 1011660311 | C | CALCIUM CARBONATE (CALCIUM CARBONATE) | 2 | |||||||
| 6202955 | 1011660312 | C | COLECALCIFEROL (COLECALCIFEROL) | 2 | |||||||
| 6202955 | 1011660313 | C | DIGOXIN | 1 | |||||||
| 6202955 | 1011660314 | C | LOSARTAN POTASSIUM | 1 | |||||||
| 6202955 | 1011660315 | C | OMEPRAZOLE | 1 | |||||||
| 6202955 | 1011660316 | C | DILTIAZEM HCL | 1 | |||||||
| 6202955 | 1011660317 | C | TAMSULOSIN HCL | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6202955 | 1011628960 | OSTEOPOROSIS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6202955 | DE |
| 6202955 | HO |
| 6202955 | LT |
Reactions reported
| Event ID | PT |
|---|---|
| 6202955 | STEVENS-JOHNSON SYNDROME |
| 6202955 | TOXIC EPIDERMAL NECROLYSIS |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 6202955 | HP |
| 6202955 | OTH |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6202955 | 1011628960 | 20090310 | 20090324 | 15 | DAY |